See more : Rollatainers Limited (ROLLT.NS) Income Statement Analysis – Financial Results
Complete financial analysis of Atlas Arteria Limited (ALX.AX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Atlas Arteria Limited, a leading company in the Industrial – Infrastructure Operations industry within the Industrials sector.
- VistaGen Therapeutics, Inc. (VTGN) Income Statement Analysis – Financial Results
- II-VI Incorporated (IIVI) Income Statement Analysis – Financial Results
- NICE Ltd. (NCSYF) Income Statement Analysis – Financial Results
- Skandinaviska Enskilda Banken AB (publ) (SVKEF) Income Statement Analysis – Financial Results
- La Française de l’Energie S.A. (LFDE.PA) Income Statement Analysis – Financial Results
Atlas Arteria Limited (ALX.AX)
Industry: Industrial - Infrastructure Operations
Sector: Industrials
Website: https://www.atlasarteria.com
About Atlas Arteria Limited
Atlas Arteria Limited owns, develops, and operates toll roads. It holds a 13.4% interest in 22-kilometer toll road investors partnership II (TRIP II), the concessionaire for Dulles Greenway toll road located in Virginia, the United States. The company was formerly known as Macquarie Atlas Roads Limited and changed its name to Atlas Arteria Limited in May 2018. Atlas Arteria Limited was incorporated in 2009 and is based in Melbourne, Australia.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 134.00M | 118.24M | 100.52M | 104.56M | 167.76M | 132.38M | 83.23M | 2.69M | 2.21M | 1.47M | 890.00K | 89.60M | 87.46M | 94.72M |
Cost of Revenue | 117.60M | 118.13M | 109.56M | 118.10M | 128.62M | 32.13M | 15.25M | 65.18M | 929.00K | 0.00 | 0.00 | 5.18M | 0.00 | 0.00 |
Gross Profit | 16.40M | 116.00K | -9.05M | -13.55M | 39.14M | 100.25M | 67.98M | -62.49M | 1.28M | 1.47M | 890.00K | 84.42M | 87.46M | 94.72M |
Gross Profit Ratio | 12.24% | 0.10% | -9.00% | -12.96% | 23.33% | 75.73% | 81.68% | -2,319.41% | 58.00% | 100.00% | 100.00% | 94.22% | 100.00% | 100.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 33.20M | 9.77M | 4.75M | 7.51M | 33.89M | 119.30M | 48.41M | 101.40M | 29.34M | 797.00K | 736.00K | 36.07M | 36.21M | 33.80M |
Selling & Marketing | 0.00 | 13.69M | 11.12M | 9.63M | 7.84M | 0.00 | 0.00 | 165.49M | 28.41M | 82.12M | 21.46M | 17.87M | 0.00 | 2.04M |
SG&A | 33.20M | 23.46M | 15.87M | 17.15M | 41.73M | 119.30M | 48.41M | 101.40M | 29.34M | 797.00K | 736.00K | 36.07M | 36.21M | 33.80M |
Other Expenses | 0.00 | 1.51M | 985.00K | 1.03M | -156.00K | 10.90M | 389.78M | 67.95M | -38.00K | 16.00K | 487.00K | 3.37M | 2.95M | 56.02M |
Operating Expenses | 21.50M | 23.46M | 15.87M | 17.15M | 41.73M | 62.79M | 488.65M | 295.37M | 82.88M | 83.86M | 23.53M | 88.71M | 139.05M | 93.91M |
Cost & Expenses | 139.10M | 141.59M | 125.43M | 135.25M | 170.36M | 94.91M | 503.90M | 360.55M | 82.88M | 83.86M | 33.97M | 88.71M | 139.05M | 93.42M |
Interest Income | 36.00M | 22.13M | 140.00K | 2.09M | 7.43M | 102.29M | 53.80M | 1.36M | 712.00K | 657.00K | 403.00K | 659.00K | 1.23M | 3.90M |
Interest Expense | 96.50M | 89.00M | 82.69M | 98.46M | 104.56M | 95.60M | 53.80M | 0.00 | 0.00 | 0.00 | 0.00 | 104.63M | 102.64M | 95.62M |
Depreciation & Amortization | 69.20M | 66.25M | 61.48M | 67.44M | 70.28M | 62.12M | 36.67M | 164.78M | 28.23M | 81.73M | 10.45M | 26.58M | 30.56M | 26.35M |
EBITDA | 425.70M | 63.07M | -11.95M | -93.68M | -99.06M | 218.47M | 593.30M | -166.41M | -28.90M | -82.39M | -11.51M | 31.49M | -84.23M | 87.09M |
EBITDA Ratio | 317.69% | 36.28% | 36.38% | 35.14% | 40.35% | -18.39% | 18.74% | 14,761.10% | 5,122.83% | -5,619.99% | -2,643.71% | -10.21% | -122.55% | -128.45% |
Operating Income | -5.10M | -23.35M | -24.92M | -30.69M | -2.60M | -86.46M | -21.08M | -164.78M | -28.23M | -82.39M | -33.97M | -35.73M | -137.75M | -148.02M |
Operating Income Ratio | -3.81% | -19.75% | -24.79% | -29.36% | -1.55% | -65.31% | -25.32% | -6,116.63% | -1,276.22% | -5,619.99% | -3,817.30% | -39.88% | -157.50% | -156.27% |
Total Other Income/Expenses | 265.10M | -407.17M | -463.92M | -76.21M | -16.43M | 147.21M | 526.99M | 397.66M | 113.32M | 31.83M | 64.54M | -63.99M | -256.17M | -249.44M |
Income Before Tax | 260.00M | -92.18M | -156.12M | -259.58M | -273.90M | 60.75M | 502.83M | 232.88M | 85.09M | -50.56M | 41.90M | -140.36M | -307.76M | -243.64M |
Income Before Tax Ratio | 194.03% | -77.96% | -155.32% | -248.27% | -163.27% | 45.89% | 604.19% | 8,644.47% | 3,846.61% | -3,448.57% | 4,708.31% | -156.66% | -351.89% | -257.21% |
Income Tax Expense | 3.70M | 3.19M | -35.77M | -7.69M | -9.21M | 898.00K | 16.75M | 7.77M | 5.00K | 5.00K | -22.00K | -15.93M | -18.27M | -16.00M |
Net Income | 323.50M | 266.96M | 163.70M | -99.21M | -9.82M | 59.85M | 519.58M | 225.11M | 85.08M | -50.56M | 1.42B | -124.44M | -289.49M | -142.49M |
Net Income Ratio | 241.42% | 225.78% | 162.86% | -94.89% | -5.85% | 45.21% | 624.31% | 8,355.94% | 3,846.38% | -3,448.91% | 159,940.34% | -138.89% | -331.00% | -150.42% |
EPS | 0.22 | 0.22 | 0.16 | -0.07 | -0.01 | 0.04 | 0.78 | 0.43 | 0.17 | -0.03 | 2.69 | -0.09 | -0.20 | -0.10 |
EPS Diluted | 0.22 | 0.22 | 0.16 | -0.07 | -0.01 | 0.04 | 0.78 | 0.43 | 0.17 | -0.03 | 2.69 | -0.09 | -0.20 | -0.10 |
Weighted Avg Shares Out | 1.45B | 1.45B | 1.45B | 1.45B | 1.45B | 1.45B | 1.45B | 1.45B | 1.45B | 1.45B | 1.45B | 1.45B | 1.45B | 1.45B |
Weighted Avg Shares Out (Dil) | 1.45B | 1.45B | 1.45B | 1.45B | 1.45B | 1.45B | 1.45B | 1.45B | 1.45B | 1.45B | 1.45B | 1.45B | 1.45B | 1.45B |
Source: https://incomestatements.info
Category: Stock Reports